enow.com Web Search

  1. Ads

    related to: her2 negative breast cancer treatment guidelines

Search results

  1. Results from the WOW.Com Content Network
  2. Breast cancer classification - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_classification

    Breast cancer classification divides breast cancer into categories according to different schemes criteria and serving a different purpose. The major categories are the histopathological type, the grade of the tumor, the stage of the tumor, and the expression of proteins and genes. As knowledge of cancer cell biology develops these ...

  3. Breast cancer management - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_management

    Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.

  4. Living Proof (2008 film) - Wikipedia

    en.wikipedia.org/wiki/Living_Proof_(2008_film)

    Release. October 18, 2008. (2008-10-18) Living Proof is a 2008 Lifetime Television film, directed by Dan Ireland. The film stars Harry Connick Jr. as Dr. Dennis Slamon, a doctor who is trying to find a cure for breast cancer. The film also stars Paula Cale, Angie Harmon, and Amanda Bynes (in her final television appearance) in supporting roles.

  5. Triple-negative breast cancer - Wikipedia

    en.wikipedia.org/wiki/Triple-negative_breast_cancer

    Triple-negative breast cancer. Triple-negative breast cancer (TNBC) is any breast cancer that either lacks or shows low levels of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) overexpression and/or gene amplification (i.e. the tumor is negative on all three tests giving the name triple ...

  6. Palbociclib - Wikipedia

    en.wikipedia.org/wiki/Palbociclib

    Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR -positive and HER2 -negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. [5][6] Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.

  7. Breast cancer - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer

    This is an accepted version of this page This is the latest accepted revision, reviewed on 19 September 2024. Cancer that originates in mammary glands Medical condition Breast cancer An illustration of breast cancer Specialty Oncology Symptoms A lump in a breast, a change in breast shape, dimpling of the skin, fluid from the nipple, a newly inverted nipple, a red scaly patch of skin on the ...

  1. Ads

    related to: her2 negative breast cancer treatment guidelines